3 papers4 findings
GLP-1 receptor agonists
upin humans1
GLP-1 receptor agonists improve glycaemic control in humans.
“showing significant benefit in glycaemic control and weight loss.”
Review
GLP-1 receptor agonists in cardiovascular disease: a guide for cardiologists
The British journal of cardiology4 Aug 2026
Resistance training
upin humans1
Resistance training improves glycaemic control in humans.
“Both interventions demonstrated improvements in glycaemic control, lipid profile, cardiovascular parameters and behavioral outcomes”
Human trialin patients with type 2 diabetes mellitusn = 60
Bioinformation30 Jun 2026
Aerobic exercise
upin humans1
Aerobic exercise improves glycaemic control in humans.
“Both interventions demonstrated improvements in glycaemic control, lipid profile, cardiovascular parameters and behavioral outcomes”
Human trialin patients with type 2 diabetes mellitusn = 60
Bioinformation30 Jun 2026
Testosterone
upin humans1
Testosterone improves glycaemic control in humans.
“Reductions in BMI and waist circumference, and improvements in glycaemic control and lipid profiles, are observed in T-deficient men receiving T therapy.”
Reviewin T-deficient menmales
European cardiology11 Jul 2019
Bodyweight fell by up to 18.8% with weekly retatrutide compared with 5.1% on placebo at week 80 in adults with obesity and type 2 diabetes.Bodyweight fell by up to 18.8% with weekly retatrutide compared with 5.1% on placebo at week 80 in adults with obesity and type 2 diabetes.